Congress expands Medicare for ALS patients, guarantees specialized care coverage
H.R. 7336 — ALS Better Care Act · Filed by Jan Schakowsky (D-IL) · 14 cosponsors · Introduced Feb 3, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill expands Medicare coverage for specialized ALS (amyotrophic lateral sclerosis) care services—including physician support, physical therapy, speech pathology, respiratory care, and nursing coordination—and establishes a new bundled payment system starting January 2027. Providers treating ALS patients receive a single annual payment ($800 in 2027, adjusted annually) for these services, with additional payments for clinical trial participation and new technologies. The bill also requires a federal report on barriers to ALS clinical trial staffing and funding.
Why we flagged it
The bill's core function is to expand Medicare coverage and establish reimbursement for specialized ALS care services. It is a targeted public-health measure addressing a specific disease population with inadequate access to multidisciplinary care.
What the text implies
- The $800 base payment is fixed for 2027–2028 and then indexed to an 'ALS services market basket' defined by the Secretary—creating potential for payment erosion if cost growth outpaces the index, or conversely, overpayment if the index is set generously.
- Comptroller General reports every three years may recommend higher payments, but only in 'applicable years' (2030, 2033, etc.), creating a lag in responsiveness to actual cost changes in off-years.
- The bill requires 'notice and comment rulemaking' for qualified provider standards, but the Secretary has broad discretion to define requirements 'in consultation with' stakeholders—leaving room for regulatory capture or inconsistent enforcement.
- Telehealth is mentioned in findings but not explicitly carved out in the payment mechanism; coverage may depend on Secretary's implementation rules, creating uncertainty for rural ALS patients.
- Clinical trial payment adjustments are discretionary ('as determined by Sec.'), not mandatory, potentially limiting incentives for trial participation if the Secretary sets thresholds high.
Who it affects
ALS patients gain guaranteed Medicare coverage for specialized multidisciplinary care services previously reimbursed inadequately or inconsistently, reducing out-of-pocket costs and improving access—especially for rural patients via telehealth. Providers receive predictable bundled payments, incentivizing investment in ALS clinics and clinical trials. The primary beneficiaries are ALS patients and their families, a vulnerable population with a fatal disease.
Who stands to gain
- ALS specialty clinics and multidisciplinary care centers
- Healthcare providers (physicians, nurse practitioners, therapists, nurses)
- Durable medical equipment suppliers
- Clinical research organizations conducting ALS trials
Named in the bill
Medicare, Social Security Act (Section 1861, 1833, 1834), Secretary of Health and Human Services, Comptroller General of the US, National Institute of Neurological Disorders and Stroke, National Institutes of Health, clinicaltrials.gov, American Medical Association (Specialty Society Relative Value Scale Update Committee), ICD-10-CM coding system
Where it stands
14 cosponsors: 11 Democrats, 3 Republicans.
- Feb 3, 2026 — Introduced · Congress.gov: “Introduced in House”
- Feb 3, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
2 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $60,000 in lobbying spend. A filing names 36 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 41% of bills with at least one filing.
Jan Schakowsky, the sponsor, reported $88,051 in PAC receipts in the 2026 cycle.
- I Am Als — $30,000 on 1 filing
- The Als Association — $30,000 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the full bill text on Jul 9, 2026; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Congress expands Medicare for ALS patients, guarantees specialized care coverage” QuorumCivic. https://share.quorumcivic.app/bill/119/hr7336 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.